|
Includes all of these presentations from this session:
| # |
Presentation |
Speaker |
| 1 |
Protease-activated receptors in BE and EAC |
W.A. Phillips (Melbourne) |
| 2 |
Oncogenic Linage survival in Barrett?s esophagus |
D.G. Beer (Ann Arbor) |
| 3 |
MiRNA in BE |
A. Bansal (Kansas City) |
| 4 |
Metaplasia and EAC ? Role of Micro Satellite Instability |
M. Upton (Seattle) |
| 5 |
Use of histologic and serum DCLK 1 expression for progression of BE to EAC |
K.J. Vega (Oklahoma City) |
| 6 |
Stromal response to systemic derangements in BE |
P. Iyer (Rochester, MN) |
| 7 |
Oxidative stress in Barrett's tumorigenesis |
W. El-Rifai (Nashville) |
| 8 |
Epithelial - Mesenchymal interactions in BE |
M.K. Gibson (Cleveland) |
| 9 |
Morphogens in BE |
K.K. Krishnadath (Amsterdam) |
| 10 |
In vivo modeling of Barrett's esophagus |
L.X. Chen (Durham) |
| 11 |
In-vitro models of Barrett?s metaplasia and carcinogenesis |
K.M. Das (New Brunswick) |
| 12 |
Is there a role for MGMT (Methyl Guanine Methyl Transferase) biomarker in the management of esophageal adenocarcinoma? |
M. Lisovsky (Lebanon) |
|
